最新发布

Ekonoke harnesses indoor hops farming to safeguard beer brewers’ supply chains

A few years ago, a widely cited study said climate change would make beer taste worse and cost more in the future thanks…

从杂质到贸易风险:澳大利亚为何重新审视甲基毒死蜱

世界农化网中文网报道: 澳大利亚农药和兽药管理局(APVMA)近日宣布,将对甲基毒死蜱(chlorpyrifos-methyl)启动重新评审。此次评审涵盖所有含有该活性成分的产品、相关标签批准以及甲基毒死蜱作为活性成分的批准。

Boehringer/Zealand obesity drug delivers Phase III weight loss, but side effects raise questions

In the Phase III Synchronize-1 trial, adults with obesity or overweight without type 2 diabetes treated with survodutide lost up to 16.6% of body weight after 76 weeks, compared with 3.2% in the placebo group. Boehringer also reported reductions of up to 34% in visceral fat, the fat surrounding internal organs, compared with 12% for placebo. The company said weight loss was mainly driven by reductions in fat mass, with no more than 10.8% of total tissue-mass change coming from lean tissue at the highest dose.

Incyte to Acquire Vega Therapeutics for Up-to-$2B, Growing Hematology Pipeline with Phase III VWD Candidate

Incyte has agreed to acquire Vega Therapeutics for up to $2 billion, the companies said, in a deal designed to bolster the buyer’s hematology pipeline with antibody assets led by VGA039, a Phase III candidate for von Willebrand disease (VWD).

Sixteen44 prepares farm demo for plasma-based methane abatement tech

Swiss methane abatement startup Sixteen44 is preparing to deploy its first operational field demo unit at a farm in Swit…

Bial drops pariceract after Phase IIb failure in GBA-associated Parkinson’s

The Phase IIb ACTIVATE study enrolled 273 genetically confirmed GBA-PD patients across 85 clinical sites in 11 countries in Europe and North America. According to Bial, the randomised trial did not meet its primary endpoint or key secondary efficacy endpoints, with pariceract failing to demonstrate significant differentiation from placebo. The company said the drug was generally well tolerated and no unexpected safety concerns emerged, but it will stop further development of the programme in this indication.

Complete Connectome of Fruit Fly Central Nervous System Now Open-Source

A new study published in  Nature  titled, “ Distributed control circuits across a brain-and-cord connectome ”, describes a complete wiring diagram of all the connections between neurons in the central nervous system of an adult fruit fly for translational applications.

Fyteko十年进阶:从信号分子生物刺激素到全球产业生态,领航气候农业新赛道

编者按:全球气候变暖导致干旱、高温、水涝等非生物胁迫频发,持续制约农作物稳产提质,成为现代农业可持续发展的核心瓶颈。同时,全球农业加速向绿色、精准、低碳转型,农药减量、生态种植、气候韧性种植成为主流趋势,在此背景下,2014年成立的比利时生物科创企业Fyteko,依托原创植物信号分子核心技术,走出″技术筑基、产品赋能、全球拓市、资本提速″的高质量发展路径。本文依托世界农化网十余年跟踪报道及企业公开资讯,从七大核心维度复盘Fyteko十年发展历程,拆解其创新与商业化逻辑,为科创型生物农企发展提供可复制的行业借鉴。

红太阳股份推进子公司债务重组,化解3.83亿元存量债务优化财务结构

世界农化网中文网报道:南京红太阳股份有限公司(简称″红太阳″)6月9日公告,公司及全资子公司南京红太阳生物化学有限责任公司、南京红太阳国际贸易有限公司已与宁波金融资产管理股份有限公司(简称″宁波AMC″)签署《债务重组协议》及相关附属文件,拟通过债权收购、债务豁免与资产担保组合安排,化解两子公司合计约3.83亿元的历史存量金融债务。

农药标委会发布命名新规:分类施策、覆盖核酸农药等新兴领域

世界农化网中文网报道:近期,全国农药标准化技术委员会发布了三项关于农药中文通用名称命名的规范性文件,分别为《农药中文通用名称命名工作程序》《农药中文通用名称命名指导原则》《农药中文通用名称命名资料要求》。文件自发布之日起实施。